Rochester Epidemiology Project

Last updated
Rochester Epidemiology Project
AbbreviationREP
Formation1966
Type
  • Community-based health research project
  • Records-linkage system
Legal statusNIH-funded project
PurposeResearch
Location
  • Rochester, Minnesota
Region served
  • Southern Minnesota
  • Western Wisconsin
  • The geographic region of the Expanded Rochester Epidemiology Project (REP).svg
Principal Investigators
  • Walter A. Rocca, MD, MPH
  • Jennifer St. Sauver, PhD, MPH
Website rochesterproject.org

The Rochester Epidemiology Project (REP) is a unique records-linkage research infrastructure that has existed since 1966, and allows for population-based medical research in Olmsted County, Minnesota and an expanded region of 27 counties in Southern Minnesota and Western Wisconsin. The project has been continually funded by the National Institutes of Health since 1966. Specifically, the REP links medical data (diagnosis, procedure, prescription medication, laboratory testing) to unique persons across the many participating medical providers in the region. The project is a collaboration between Olmsted Medical Center, Mayo Clinic, Olmsted County Public Health Services, Mayo Clinic Health System, Zumbro Valley Health Center, and many other historical partners.

Contents

History

The REP was originally funded by the National Institute of General Medical Sciences in 1966 under the direction of Dr. Leonard T. Kurland, [1] a neurologist who started his career at the NIH and moved to Olmsted County, Minnesota when he realized the great benefit to medical research that a population-based records-linkage system could have. [2] [3] [4] [5] Dr. Kurland considered Olmsted County an optimal location for such a population-based research infrastructure because the county is relatively isolated from other metropolitan centers, almost all medical care is received within the county, and all medical specialties are available to county residents. [4] More recently, the study funding source changed to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, and as of July 2010 the REP is funded by the National Institute on Aging. [3] In September 2016, the REP celebrated 50 years of continuous NIH funding. [6] More recently, the REP is also supported by the Mayo Clinic Research Committee and by data access fees paid annually by individual projects using the REP for their research. [7]

The population

Original REP

The REP was originally designed to completely cover the health experience of the local population of Olmsted County, Minnesota. [4] The REP includes the medical records of all persons who have ever lived in Olmsted County, Minnesota, from January 1, 1966 to the present, and who have given permission for their medical information to be used for research under Minnesota Research Authorization regulations. [8] The Olmsted County population comprises more than 500,000 unique persons and more than 6 million person-years of follow-up through 2010. [2] [9] Historically, the Olmsted County population is less racially diverse and is more highly educated than the US as a whole; however, it has been found to be similar to the state of Minnesota and surrounding states (Wisconsin, Iowa, North Dakota, and South Dakota). [10] The Olmsted County population encompasses about 160,000 persons as of the 2020 US Decennial Census.

Expanded REP

Beginning in 2010, the linkage of electronic medical data from a region extending beyond the Olmsted County, Minnesota area became possible. In 2018, REP authors extensively described an expanded 27-county region of Southern Minnesota (19 counties: Brown, Watonwan, Martin, Nicollet, Blue Earth, Faribault, Le Sueur, Waseca, Freeborn, Rice, Steele, Goodhue, Dodge, Mower, Olmsted, Wabasha, Winona, Fillmore, and Houston) and Western Wisconsin (8 counties: La Crosse, Trempealeau, Buffalo, Pepin, Eau Claire, Barron, Dunn, and Chippewa) [11] The expanded REP captures and links the medical data of nearly 700,000 persons from the year 2010 to present (about 60% of the 27-county region as compared to the US Census). [11] The REP has created a data sharing tool called the Data Exploration Portal where researchers can explore the medical and personal characteristics of this population. [12] [13] The expansion of the REP to a larger region and population has also made the study of very rare conditions possible. [14]

Scientific contributions

The REP has contributed significantly to the understanding of many diseases, including epilepsy, [15] rheumatoid arthritis, [16] osteoporosis, [17] Parkinson's disease, [18] dementia and Alzheimer's disease, [19] heart failure, [20] stroke, [21] multiple myeloma, [22] deep vein thrombosis, [23] multimorbidity, [24] [25] and many others. Since its inception, the REP has supported more than 3,000 peer-reviewed scientific publications spanning almost every field of medicine. [6] [7]

Related Research Articles

<span class="mw-page-title-main">Epidemiology</span> Study of health and disease within a population

Epidemiology is the study and analysis of the distribution, patterns and determinants of health and disease conditions in a defined population.

<span class="mw-page-title-main">MMR vaccine</span> Any of several combined vaccines against measles, mumps, and rubella

The MMR vaccine is a vaccine against measles, mumps, and rubella, abbreviated as MMR. The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least four weeks between the doses. After two doses, 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella. The vaccine is also recommended for those who do not have evidence of immunity, those with well-controlled HIV/AIDS, and within 72 hours of exposure to measles among those who are incompletely immunized. It is given by injection.

<span class="mw-page-title-main">Rochester, Minnesota</span> City in Minnesota, United States

Rochester is a city in the U.S. state of Minnesota and the county seat of Olmsted County. Located on rolling bluffs on the Zumbro River's south fork in Southeast Minnesota, the city is the home and birthplace of the renowned Mayo Clinic.

<span class="mw-page-title-main">Mayo Clinic</span> American academic medical center

Mayo Clinic is a nonprofit American academic medical center focused on integrated health care, education, and research. It employs over 7,300 physicians and scientists, along with another 66,000 administrative and allied health staff, across three major campuses: Rochester, Minnesota; Jacksonville, Florida; and Phoenix/Scottsdale, Arizona. The practice specializes in treating difficult cases through tertiary care and destination medicine. It is home to the top-15 ranked Mayo Clinic Alix School of Medicine in addition to many of the highest regarded residency education programs in the United States. It spends over $660 million a year on research and has more than 3,000 full-time research personnel.

Oophorectomy, historically also called ovariotomy is the surgical removal of an ovary or ovaries. The surgery is also called ovariectomy, but this term is mostly used in reference to animals, e.g. the surgical removal of ovaries from laboratory animals. Removal of the ovaries of females is the biological equivalent of castration of males; the term castration is only occasionally used in the medical literature to refer to oophorectomy of women. In veterinary medicine, the removal of ovaries and uterus is called ovariohysterectomy (spaying) and is a form of sterilization.

<span class="mw-page-title-main">Shingles</span> Viral disease caused by the varicella zoster virus

Shingles, also known as herpes zoster, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide mark either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Other common symptoms are fever, headache, and tiredness. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.

<span class="mw-page-title-main">Polycythemia vera</span> Overproduction of red blood cells by the bone marrow

In oncology, polycythemia vera is an uncommon myeloproliferative neoplasm in which the bone marrow makes too many red blood cells.

<span class="mw-page-title-main">Case–control study</span> Type of observational study comparing two existing groups differing in outcome

A case–control study is a type of observational study in which two existing groups differing in outcome are identified and compared on the basis of some supposed causal attribute. Case–control studies are often used to identify factors that may contribute to a medical condition by comparing subjects who have that condition/disease with patients who do not have the condition/disease but are otherwise similar. They require fewer resources but provide less evidence for causal inference than a randomized controlled trial. A case–control study is often used to produce an odds ratio, which is an inferior measure of strength of association compared to relative risk, but new statistical methods make it possible to use a case-control study to estimate relative risk, risk differences, and other quantities.

Record linkage is the task of finding records in a data set that refer to the same entity across different data sources. Record linkage is necessary when joining different data sets based on entities that may or may not share a common identifier, which may be due to differences in record shape, storage location, or curator style or preference. A data set that has undergone RL-oriented reconciliation may be referred to as being cross-linked.

<span class="mw-page-title-main">Framingham Heart Study</span> Cardiovascular cohort study

The Framingham Heart Study is a long-term, ongoing cardiovascular cohort study of residents of the city of Framingham, Massachusetts. The study began in 1948 with 5,209 adult subjects from Framingham, and is now on its third generation of participants. Prior to the study almost nothing was known about the epidemiology of hypertensive or arteriosclerotic cardiovascular disease. Much of the now-common knowledge concerning heart disease, such as the effects of diet, exercise, and common medications such as aspirin, is based on this longitudinal study. It is a project of the National Heart, Lung, and Blood Institute, in collaboration with Boston University. Various health professionals from the hospitals and universities of Greater Boston staff the project.

<span class="mw-page-title-main">Pulmonary fibrosis</span> Disease that causes scarring of the lungs

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.

<span class="mw-page-title-main">Monoclonal gammopathy of undetermined significance</span> Medical condition

Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell dyscrasia in which plasma cells or other types of antibody-producing cells secrete a myeloma protein, i.e. an abnormal antibody, into the blood; this abnormal protein is usually found during standard laboratory blood or urine tests. MGUS resembles multiple myeloma and similar diseases, but the levels of antibodies are lower, the number of plasma cells in the bone marrow is lower, and it rarely has symptoms or major problems. However, since MGUS can lead to multiple myeloma, which develops at the rate of about 1.5% a year, or other symptomatic conditions, yearly monitoring is recommended.

<span class="mw-page-title-main">Collagenous colitis</span> Medical condition

Collagenous colitis is an inflammatory condition of the colon. Together with the related condition lymphocytic colitis, it is a subtype of microscopic colitis, which is characterized by inflammation that specifically affects the colon, and a clinical presentation that involves watery diarrhea but a lack of rectal bleeding. Microscopic colitis does not usually cause macroscopic changes to the colon that allow a visual diagnosis during colonoscopy, instead causing microscopic changes that can be detected through histopathological examination of colonic biopsies. The nature of these microscopic changes is what differentiates collagenous from lymphocytic colitis, with the characteristic finding in collagenous colitis being depositions of collagen in the connective tissue between the colonic glands. Collagenous colitis, and microscopic colitis as a whole, is sometimes considered to be an inflammatory bowel disease (IBD) along with Crohn's disease and ulcerative colitis. However, little is known about the etiology of microscopic colitis, and so the degree of similarity to the inflammatory bowel diseases is uncertain.

The epidemiology of autism is the study of the incidence and distribution of autism spectrum disorders (ASD). A 2022 systematic review of global prevalence of autism spectrum disorders found a median prevalence of 1% in children in studies published from 2012 to 2021, with a trend of increasing prevalence over time. However, the study's 1% figure may reflect an underestimate of prevalence in low- and middle-income countries.

<i>Histoplasma capsulatum</i> Species of fungus

Histoplasma capsulatum is a species of dimorphic fungus. Its sexual form is called Ajellomyces capsulatus. It can cause pulmonary and disseminated histoplasmosis.

Gastroparesis, also called delayed gastric emptying, is a medical disorder consisting of weak muscular contractions (peristalsis) of the stomach, resulting in food and liquid remaining in the stomach for a prolonged period of time. Stomach contents thus exit more slowly into the duodenum of the digestive tract. This can result in irregular absorption of nutrients, inadequate nutrition, and poor glycemic control.

Molecular epidemiology is a branch of epidemiology and medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations. This field has emerged from the integration of molecular biology into traditional epidemiological research. Molecular epidemiology improves our understanding of the pathogenesis of disease by identifying specific pathways, molecules and genes that influence the risk of developing disease. More broadly, it seeks to establish understanding of how the interactions between genetic traits and environmental exposures result in disease.

In epidemiology, ecological studies are used to understand the relationship between outcome and exposure at a population level, where 'population' represents a group of individuals with a shared characteristic such as geography, ethnicity, socio-economic status of employment. What differentiates ecological studies from other studies is that the unit analysis being studied is the group, therefore inferences cannot be made about individual study participants. On the other hand, details of outcome and exposure can be generalized to the population being studied. Examples of such studies include investigating associations between units of grouped data, such as electoral wards, regions, or even whole countries.

Mega2 allows the applied statistical geneticist to convert one's data from several input formats to a large number output formats suitable for analysis by commonly used software packages. In a typical human genetics study, the analyst often needs to use a variety of different software programs to analyze the data, and these programs usually require that the data be formatted to their precise input specifications. Conversion of one's data into these multiple different formats can be tedious, time-consuming, and error-prone. Mega2, by providing validated conversion pipelines, can accelerate the analyses while reducing errors.

<span class="mw-page-title-main">Mayo Clinic Alix School of Medicine</span> Medical school in Minnesota, Arizona and Florida

The Mayo Clinic Alix School of Medicine (MCASOM), formerly known as Mayo Medical School (MMS), is a research-oriented medical school based in Rochester, Minnesota, with additional campuses in Arizona and Florida. MCASOM is a school within the Mayo Clinic College of Medicine and Science (MCCMS), the education division of the Mayo Clinic. It grants the Doctor of Medicine (M.D.) degree, accredited by the Higher Learning Commission (HLC) and the Liaison Committee on Medical Education (LCME). In November 2018, the school was renamed in honor of a $200 million donation from businessman Jay Alix.

References

  1. Whisnant JP; Mulder DW. (2002). "Leonard T. Kurland: 1921-2001". Annals of Neurology. 51 (5): 663. doi:10.1002/ana.10183. PMID   12112123.
  2. 1 2 St Sauver JL; Grossardt BR; Yawn BP; Melton LJ 3rd; Pankratz JJ; Brue SM; Rocca WA. (2012). "Data Resource Profile: The Rochester Epidemiology Project (REP) medical records-linkage system". Int J Epidemiol. 41 (6): 1614–24. doi:10.1093/ije/dys195. PMC   3535751 . PMID   23159830.
  3. 1 2 Rocca WA; Yawn BP; St Sauver JL; Grossardt BR; Melton LJ. (2012). "History of the Rochester Epidemiology Project: Half a Century of Medical Records Linkage in a US Population". Mayo Clin. Proc. 87 (12): 1202–13. doi:10.1016/j.mayocp.2012.08.012. PMC   3541925 . PMID   23199802.
  4. 1 2 3 Melton LJ III. (1996). "History of the Rochester Epidemiology Project". Mayo Clin. Proc. 71 (3): 266–274. doi: 10.4065/71.3.266 . PMID   8594285.
  5. Kurland LT; Molgaard CA. (1981). "The patient record in epidemiology". Scientific American. 245 (4): 54–63. Bibcode:1981SciAm.245d..54K. doi:10.1038/scientificamerican1081-54. PMID   7027437.
  6. 1 2 Boese Brett (27 September 2016). "A 'hidden gem' at Mayo celebrates 50 years". PostBulletin. Retrieved 3 October 2016.
  7. 1 2 "Rochester Epidemiology Project: About Us". Rochester Epidemiology Project. Retrieved 26 May 2022.
  8. "What Consent? - MN's Medical & Genetic Research Law" (PDF). February 2005. Archived from the original (PDF) on October 21, 2013. Retrieved December 14, 2012.
  9. St Sauver JL; Grossardt BR; Yawn BP; Melton LJ 3rd; Rocca WA. (2011). "Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project". Am J Epidemiol. 173 (9): 1059–68. doi:10.1093/aje/kwq482. PMC   3105274 . PMID   21430193.
  10. St Sauver JL; Grossardt BR; Leibson CL; Yawn BP; Melton LJ 3rd; Rocca WA. (2012). "Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project". Mayo Clin. Proc. 87 (2): 151–60. doi:10.1016/j.mayocp.2011.11.009. PMC   3538404 . PMID   22305027.
  11. 1 2 Rocca WA; Grossardt BR; Brue SM; Bock-Goodner CM; Chamberlain AM; Wilson PM; Finney Rutten LJ; St Sauver JL. (2018). "Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP)". Int J Epidemiol. 47 (2): 368–368j. doi:10.1093/ije/dyx268. PMC   5913632 . PMID   29346555.
  12. St Sauver JL; Grossardt BR; Finney Rutten LJ; Roger VL; Majerus M; Jensen DW; Brue SM. (2018). "Rochester Epidemiology Project Data Exploration Portal". Int J Epidemiol. 15: E42. doi:10.5888/pcd15.170242. PMC   5912927 . PMID   29654640.
  13. "Rochester Epidemiology Project: Data Exploration Portal". REP Data Exploration Portal. Retrieved 26 May 2022.
  14. Naddaf E; Shelly S; Mandrekar J; Chamberlain AM; Hoffman EM; Ernste FC; Liewluck T. (2022). "Survival and associated comorbidities in inclusion body myositis". Rheumatology (Oxford). 61 (5): 2016–2024. doi:10.1093/rheumatology/keab716. PMC   9071572 . PMID   34534271.
  15. Wirrell EC; Grossardt BR; Wong-Kisiel LC; Nickels KC. (2011). "Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study". Epilepsy Res. 95 (1–2): 110–118. doi:10.1016/j.eplepsyres.2011.03.009. PMC   3260338 . PMID   21482075.
  16. Maradit Kremers H; Crowson CS; Gabriel SE. (2004). "Rochester Epidemiology Project: A unique resource for research in the rheumatic diseases". Rheum Dis Clin N Am. 30 (4): 819–34. doi:10.1016/j.rdc.2004.07.010. PMID   15488695.
  17. Richelson LS; Wahner HW; Melton LJ III; Riggs BL. (1984). "Relative contributions of aging and estrogen deficiency to postmenopausal bone loss". N Engl J Med. 311 (20): 1273–5. doi:10.1056/NEJM198411153112002. PMID   6493283.
  18. Savica R; Grossardt BR; Bower JH; Ahlskog JE; Rocca WA. (2016). "Time Trends in the Incidence of Parkinson Disease". JAMA Neurology. 73 (8): 981–989. doi:10.1001/jamaneurol.2016.0947. PMC   5004732 . PMID   27323276.
  19. Roberts RO; Geda YE; Knopman DS; Cha RH; Pankratz VS; Boeve BF; Tangalos EG; Ivnik RJ; Rocca WA; Petersen RC (2012). "The incidence of MCI differs by subtype and is higher in men: The Mayo Clinic Study of Aging". Neurology. 78 (5): 342–351. doi:10.1212/WNL.0b013e3182452862. PMC   3280046 . PMID   22282647.
  20. Hellermann JP; Goraya TY; Jacobsen SJ; Weston SA; Reeder GS; Gersh BJ; Redfield MM; Rodeheffer RJ; Yawn BP; Roger VL. (2003). "Incidence of heart failure after myocardial infarction: Is it changing over time?". Am J Epidemiol. 157 (12): 1101–7. doi: 10.1093/aje/kwg078 . PMID   12796046.
  21. Whisnant JP; O'Fallon WM; Sicks J; Ingall T. (1993). "Stroke incidence with hypertension and ischemic heart disease in Rochester, Minnesota". Annals of Epidemiology. 3 (5): 480–2. doi:10.1016/1047-2797(93)90100-i. PMID   8167822.
  22. Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Melton LJ III (2004). "Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades". Cancer. 101 (11): 2667–74. doi: 10.1002/cncr.20652 . PMID   15481060. S2CID   36502921.
  23. Silverstein MD; Heit JA; Mohr DN; Petterson TM; O’Fallon WM; Melton LJ 3rd. (1998). "Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study". Arch. Intern. Med. 158 (6): 585–593. doi:10.1001/archinte.158.6.585. PMID   9521222.
  24. St Sauver JL; Boyd CM; Grossardt BR; Bobo WV; Finney Rutten LJ; Roger VL; Ebbert JO; Therneau TM; Yawn BP; Rocca WA. (2015). "Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity". BMJ Open. 5 (2): e006413. doi:10.1136/bmjopen-2014-006413. PMC   4322195 . PMID   25649210.
  25. Rocca WA; Grossardt BR; Boyd CM; Chamberlain AM; Bobo WV; St Sauver JL. (2021). "Multimorbidity, ageing and mortality: normative data and cohort study in an American population". BMJ Open. 11 (3): e042633. doi:10.1136/bmjopen-2020-042633. PMC   7986688 . PMID   33741663.